| The epidemiology of multiple sclerosis in Europe M Pugliatti, G Rosati, H Carton, T Riise, J Drulovic, L Vécsei, I Milanov European journal of Neurology 13 (7), 700-722, 2006 | 1001 | 2006 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 966 | 2018 |
| Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures GL Krauss, JM Serratosa, V Villanueva, M Endziniene, Z Hong, J French, ... Neurology 78 (18), 1408-1415, 2012 | 485 | 2012 |
| Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients G Sandrini, P Rossi, I Milanov, M Serrao, AP Cecchini, G Nappi Cephalalgia 26 (7), 782-789, 2006 | 316 | 2006 |
| Therapeutic use of nicergoline B Winblad, M Fioravanti, T Dolezal, I Logina, IG Milanov, DC Popescu, ... Clinical drug investigation 28, 533-552, 2008 | 229 | 2008 |
| Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response … GL Krauss, P Klein, C Brandt, SK Lee, I Milanov, M Milovanovic, ... The Lancet Neurology 19 (1), 38-48, 2020 | 226 | 2020 |
| Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ... Parkinsonism & related disorders 45, 13-20, 2017 | 191 | 2017 |
| Electromyographic differentiation of tremors I Milanov Clinical Neurophysiology 112 (9), 1626-1632, 2001 | 124 | 2001 |
| Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine G Sandrini, AP Cecchini, I Milanov, C Tassorelli, MG Buzzi, G Nappi Neuroscience letters 317 (3), 135-138, 2002 | 117 | 2002 |
| Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b … A Shoamanesh, H Mundl, EE Smith, J Masjuan, I Milanov, T Hirano, ... The Lancet 400 (10357), 997-1007, 2022 | 99 | 2022 |
| Mechanisms of baclofen action on spasticity IG Milanov Acta neurologica scandinavica 85 (5), 305-310, 1992 | 90 | 1992 |
| Effects of hypnosis on diffuse noxious inhibitory controls G Sandrini, I Milanov, S Malaguti, MP Nigrelli, A Moglia, G Nappi Physiology & behavior 69 (3), 295-300, 2000 | 72 | 2000 |
| F-wave for assessment of segmental motoneurone excitability. IG Milanov Electromyography and clinical neurophysiology 32 (1-2), 11-15, 1992 | 70 | 1992 |
| Mechanisms of tizanidine action on spasticity I Milanov, D Georgiev Acta neurologica scandinavica 89 (4), 274-279, 1994 | 68 | 1994 |
| A comparison of methods to assess the excitability of lower motoneurones IG Milanov Canadian journal of neurological sciences 19 (1), 64-68, 1992 | 65 | 1992 |
| Asymmetrical reduction of the nociceptive flexion reflex threshold in cluster headache G Sandrini, F Antonaci, S Lanfranchi, I Milanov, A Danilov, G Nappi Cephalalgia 20 (7), 647-652, 2000 | 63 | 2000 |
| Examination of the segmental pathophysiological mechanisms of spasticity. I Milanov Electromyography and clinical neurophysiology 34 (2), 73-79, 1994 | 63 | 1994 |
| Trigemino-cervical reflex in patients with headache I Milanov, D Bogdanova Cephalalgia 23 (1), 35-38, 2003 | 61 | 2003 |
| Effects of sleep on spinal nociceptive reflexes in humans G Sandrini, I Milanov, B Rossi, L Murri, E Alfonsi, A Moglia, G Nappi Sleep 24 (1), 13-17, 2001 | 55 | 2001 |
| Update on the management of Parkinson’s disease for general neurologists Z Pirtošek, O Bajenaru, N Kovács, I Milanov, M Relja, M Skorvanek Parkinson’s Disease 2020 (1), 9131474, 2020 | 54 | 2020 |
Christian BrandtBethel Epilepsy Centre, Mara Hospital, University Hospital for Epileptology, Bielefeld, GermanyVerified email at mara.de
